ATE203749T1 - Verfahren zur herstellung amorphen paroxetin- hydrochlorids - Google Patents

Verfahren zur herstellung amorphen paroxetin- hydrochlorids

Info

Publication number
ATE203749T1
ATE203749T1 AT97108713T AT97108713T ATE203749T1 AT E203749 T1 ATE203749 T1 AT E203749T1 AT 97108713 T AT97108713 T AT 97108713T AT 97108713 T AT97108713 T AT 97108713T AT E203749 T1 ATE203749 T1 AT E203749T1
Authority
AT
Austria
Prior art keywords
paroxetine hydrochloride
amorphic
producing
producing amorphic
hydrochloride
Prior art date
Application number
AT97108713T
Other languages
English (en)
Inventor
Shu-Zhong Wang
Takashi Okazoe
Yasushi Matsumura
Original Assignee
Asahi Glass Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Glass Co Ltd filed Critical Asahi Glass Co Ltd
Application granted granted Critical
Publication of ATE203749T1 publication Critical patent/ATE203749T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT97108713T 1996-05-30 1997-05-30 Verfahren zur herstellung amorphen paroxetin- hydrochlorids ATE203749T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13719296 1996-05-30

Publications (1)

Publication Number Publication Date
ATE203749T1 true ATE203749T1 (de) 2001-08-15

Family

ID=15192956

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97108713T ATE203749T1 (de) 1996-05-30 1997-05-30 Verfahren zur herstellung amorphen paroxetin- hydrochlorids

Country Status (6)

Country Link
US (2) US20010021776A1 (de)
EP (2) EP0810224B1 (de)
AT (1) ATE203749T1 (de)
CA (1) CA2206592A1 (de)
DE (1) DE69705896T2 (de)
ES (1) ES2160871T3 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6638948B1 (en) * 1996-09-09 2003-10-28 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
CA2193939C (en) * 1996-12-24 2002-02-12 K.S. Keshava Murthy Useful form of anhydrous paroxetine hydrochloride
HUP0000960A3 (en) * 1997-01-15 2001-04-28 Smithkline Beecham Plc Spray-dried paroxetine hydrochloride, process for it's preparation,use of the compound and pharmaceutical compositions containing the same
KR100543614B1 (ko) 1997-06-10 2006-01-20 신톤 비.브이. 4-페닐피페리딘 화합물
KR20010040711A (ko) * 1998-02-06 2001-05-15 피터 기딩스 파록세틴의 염
GB9806312D0 (en) * 1998-03-24 1998-05-20 Smithkline Beecham Plc Novel formulations
US6168805B1 (en) * 1998-05-07 2001-01-02 Endo Pharmaceuticals, Inc. Aqueous process for manufacturing paroxetine solid dispersions
GB9814316D0 (en) * 1998-07-02 1998-09-02 Smithkline Beecham Plc Novel compounds
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
ES2138937B1 (es) 1998-07-07 2000-10-01 Medichem Sa Polimorfo de maleato de paroxetina y formulaciones farmaceuticas que lo contienen.
EP1102764A1 (de) * 1998-08-08 2001-05-30 Smithkline Beecham Plc Salze von paroxetin
GB9824298D0 (en) * 1998-11-05 1998-12-30 Smithkline Beecham Plc Novel process
GB9826180D0 (en) * 1998-11-30 1999-01-20 Smithkline Beecham Plc Novel process
IN191492B (de) * 1999-05-25 2003-12-06 Ranbaxy Lab Ltd
GB9914600D0 (en) * 1999-06-22 1999-08-25 Smithkline Beecham Plc Novel,process
DE60004768T2 (de) 1999-07-01 2004-07-08 Italfarmaco S.P.A. Komplexe von paroxetin mit cyclodextrin oder cyclodextrin derivaten
HU226912B1 (en) * 2000-04-07 2010-03-01 Richter Gedeon Nyrt New paroxetin salt and medicament containing it
JPWO2002022609A1 (ja) * 2000-09-14 2004-01-22 旭硝子株式会社 実質的に有機溶媒を含まないパロキセチン塩類の製造方法
WO2002085360A1 (en) * 2001-04-25 2002-10-31 Pentech Pharmaceuticals, Inc. Optimized procedures for the manufacture of paroxetine salts
IL159280A0 (en) * 2001-06-14 2004-06-01 Teva Pharma A process for preparing paroxetine hcl which limits formation of pink colored compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
ES2058061T3 (es) * 1985-10-25 1994-11-01 Beecham Group Plc Derivado de piperidina, su preparacion y su uso como medicamento.
EP0542355A1 (de) * 1991-11-15 1993-05-19 Merck Frosst Canada Inc. Amorphe (Chinolin-2-ylmethoxy)Indole als Leukotrien-Antagonisten
IT1274241B (it) * 1993-12-03 1997-07-15 Smithkline Beecham Farma Complessi agente terapeutico/matrice polimerica dotati di migliorate caratteristiche di sapore e composizioni farmaceutiche che li contengono

Also Published As

Publication number Publication date
ES2160871T3 (es) 2001-11-16
US20030181725A1 (en) 2003-09-25
EP0810224B1 (de) 2001-08-01
DE69705896D1 (de) 2001-09-06
CA2206592A1 (en) 1997-11-30
US20010021776A1 (en) 2001-09-13
EP0810224A1 (de) 1997-12-03
EP1090918A1 (de) 2001-04-11
DE69705896T2 (de) 2002-04-11

Similar Documents

Publication Publication Date Title
ATE203749T1 (de) Verfahren zur herstellung amorphen paroxetin- hydrochlorids
ATE359994T1 (de) Verfahren zur herstellung von oxazolidinonen
DE69834673D1 (de) Verfahren zur Herstellung einer Elektronenemittierenden Quelle
NO20016226D0 (no) Fremgangsmåte for fremstilling av substituerte formamider
DE69631298D1 (de) Verfahren zur Herstellung von Paroxetinhydrochloridanhydrat
DE69621297D1 (de) Verfahren zur Herstellung wasserlöslicher organischer Silizium-Verbindungen
DE69609796D1 (de) Verfahren zur herstellung von essigsäure
DE69907037D1 (de) Verfahren zur herstellung von citalopram
DE69313515D1 (de) Verfahren zur Herstellung eines aromatischen Carbonats
ATE213237T1 (de) Verfahren zur herstellung von citalopram
DE69709164D1 (de) Verfahren zur herstellung von essigsäure
DE69634374D1 (de) Verfahren zur Herstellung einer elektronenemittierenden Vorrichtung
ATE250113T1 (de) Verfahren zur herstellung von herbiziden
DE69624825D1 (de) Eintopfverfahren zur herstellung von 2-oxazolidinonderivate
DE69805608D1 (de) Verfahren zur herstellung von epoxyverbindungen
DE69701915D1 (de) Verfahren zur Herstellung eines einbügelbaren Einlagestoffs
DE69909821D1 (de) Verfahren zur herstellung von weichem seidenpapier
DE69932993D1 (de) Verfahren zur Herstellung eines elektrophotographischen lichtempfindlichen Elementes
DE69411575D1 (de) Verfahren zur herstellung lithographischer druckformen
ATE355268T1 (de) Verfahren zur herstellung von citalopram
DE69704969D1 (de) Verfahren zur Herstellung einer photoempfinflichen Kunstoffdruckplatte
ATE353937T1 (de) Verfahren zur synthese einer oxonolverbindung
DE69721812D1 (de) Verfahren zur herstellung optisch aktiver 3-quinuclidinol derivate
DE69406004D1 (de) Verfahren zur Herstellung eines verbesserten Bilds
DE59611076D1 (de) Verfahren zur herstellung von 5,6-dihydro-1,3-oxazinen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties